in Clinical Trials
Our pipeline includes multiple regenerative medical products in varying stages of development. Our lead biotherapeutic product, realSKIN , is currently preparing for a pivotal Phase 3 clinical trial for severe burns and has concluded preclinical work for realNERVE™ in peripheral nerve repair with a corresponding IND in process.
Learn more about the clinical program on clinicaltrials.gov
Powered by a revolutionary science and steadfast commitment, XenoTherapeutics is working to quickly advance its platform to therapeutic reality. We’re redefining how regenerative medicine is discovered and developed.